CN1212132C - 治疗风湿疾病的中药及其制备方法 - Google Patents
治疗风湿疾病的中药及其制备方法 Download PDFInfo
- Publication number
- CN1212132C CN1212132C CN 02112714 CN02112714A CN1212132C CN 1212132 C CN1212132 C CN 1212132C CN 02112714 CN02112714 CN 02112714 CN 02112714 A CN02112714 A CN 02112714A CN 1212132 C CN1212132 C CN 1212132C
- Authority
- CN
- China
- Prior art keywords
- preparation
- chinese medicine
- prepared
- medicine
- radix aconiti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims abstract description 33
- 208000025747 Rheumatic disease Diseases 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 239000000843 powder Substances 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 8
- 239000002552 dosage form Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 208000006820 Arthralgia Diseases 0.000 abstract description 16
- 238000010792 warming Methods 0.000 abstract description 7
- 230000006870 function Effects 0.000 abstract description 6
- 201000003068 rheumatic fever Diseases 0.000 abstract description 2
- 241000227129 Aconitum Species 0.000 abstract 2
- 241000173529 Aconitum napellus Species 0.000 abstract 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 2
- 244000020518 Carthamus tinctorius Species 0.000 abstract 2
- 241000218671 Ephedra Species 0.000 abstract 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 2
- 235000011477 liquorice Nutrition 0.000 abstract 2
- 230000000552 rheumatic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 25
- 208000002193 Pain Diseases 0.000 description 19
- 230000036407 pain Effects 0.000 description 19
- 230000010354 integration Effects 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 12
- 230000008961 swelling Effects 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 201000010099 disease Diseases 0.000 description 11
- 206010039073 rheumatoid arthritis Diseases 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 4
- 210000003743 erythrocyte Anatomy 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 229940100691 oral capsule Drugs 0.000 description 4
- 238000004062 sedimentation Methods 0.000 description 4
- 241000905957 Channa melasoma Species 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 230000004064 dysfunction Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000000707 wrist Anatomy 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 208000018934 joint symptom Diseases 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 206010014020 Ear pain Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 240000007509 Phytolacca dioica Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000007176 earache Diseases 0.000 description 1
- 238000004134 energy conservation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000005453 pelletization Methods 0.000 description 1
- 206010034754 petechiae Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02112714 CN1212132C (zh) | 2002-02-28 | 2002-02-28 | 治疗风湿疾病的中药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02112714 CN1212132C (zh) | 2002-02-28 | 2002-02-28 | 治疗风湿疾病的中药及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1440768A CN1440768A (zh) | 2003-09-10 |
CN1212132C true CN1212132C (zh) | 2005-07-27 |
Family
ID=27768561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02112714 Expired - Lifetime CN1212132C (zh) | 2002-02-28 | 2002-02-28 | 治疗风湿疾病的中药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1212132C (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110025683A (zh) * | 2018-01-11 | 2019-07-19 | 安徽中昌医药科技有限公司 | 一种治疗类风湿性关节炎的药物 |
-
2002
- 2002-02-28 CN CN 02112714 patent/CN1212132C/zh not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CN1440768A (zh) | 2003-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1061854C (zh) | 治疗、预防妇科疾患的药物制剂 | |
CN1861163A (zh) | 一种治疗肾阳虚衰,气虚血亏的中药组合物及其制备工艺 | |
CN1342462A (zh) | 治疗类风湿性关节炎的药物组合物 | |
CN1167454C (zh) | 一种通过神阙穴进行排毒的中药组合物及其制备方法 | |
CN1698748A (zh) | 外用主治强直性脊柱炎、关节炎的纯中药及其制法 | |
CN1712054A (zh) | 秦川通痹片 | |
CN1092981C (zh) | 治疗由风寒湿所致痹症的药物及其制备方法 | |
CN1124156C (zh) | 治疗风湿病的中药丸剂及其制备方法 | |
CN1117582C (zh) | 治疗类风湿关节炎的药物及其制备方法 | |
CN1840160A (zh) | 抗骨质增生粉 | |
CN1943764A (zh) | 用于治疗乙肝和肝癌的中草药丸 | |
CN1389255A (zh) | 治疗风湿及类风湿性关节炎的中药组合物 | |
CN1843421A (zh) | 一种治疗风湿疾病的药物 | |
CN1772245A (zh) | 按摩推拿保健蛇药酒及其应用 | |
CN1212132C (zh) | 治疗风湿疾病的中药及其制备方法 | |
CN1186067C (zh) | 治疗急性筋伤的药物及其制备方法 | |
CN1060954C (zh) | 一种外用中药散剂、制备方法和药垫 | |
CN1723933A (zh) | 一种治疗中风病的中药胶囊及其生产方法 | |
CN1569095A (zh) | 一种治疗脑梗塞的药物 | |
CN1176689C (zh) | 治疗原发性痛经的药物及其制备方法 | |
CN1152704C (zh) | 抗癌口服液及其制备方法 | |
CN1232269C (zh) | 一种用于治疗皮肤疮疡症的中药外用油剂 | |
CN1762437A (zh) | 一种治疗风湿和类风湿关节炎的丸剂及其制备方法 | |
CN1850265A (zh) | 一种治疗肾阳虚证的中药及制备方法 | |
CN1733193A (zh) | 一种治疗心脏病的中药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: ANHUI JINGFANG PHARMACY CO., LTD. Free format text: FORMER OWNER: XIANG QIZHENG Effective date: 20090515 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090515 Address after: No. 8, Jing Fang Road, Xuancheng, Anhui Patentee after: Anhui Jingfang Pharmaceutical Co., Ltd. Address before: Xuancheng, Anhui Province Fang Fang Road No. 8, Anhui Fang Fang pharmaceutical, Limited by Share Ltd Patentee before: Xiang Qizheng |
|
C56 | Change in the name or address of the patentee |
Owner name: SINOPHARM GROUP JINGFANG (ANHUI) PHARMACEUTICAL CO Free format text: FORMER NAME: ANHUI JINGFANG MEDICINE INDUSTRY CO., LTD. |
|
CP03 | Change of name, title or address |
Address after: 242000 No. 16 Xuan Shui Road, Anhui, Xuancheng Patentee after: Sinopharm group (Anhui) pharmaceutical Limited by Share Ltd Address before: 242000 No. 8, Jing Fang Road, Xuancheng, Anhui Patentee before: Anhui Jingfang Pharmaceutical Co., Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20050727 |